[Pathogenetic agents in the complex treatment of patients with tuberculous pleurisy].
Data on therapy of 257 patients with tuberculous pleurisy and the clinicoroentgenological outcomes at the hospitalization stage were studied. 180 of them were treated pathogenetically in addition to the use of etiotropic drugs. The pathogenetic treatment included the use of prednisolone, tuberculin, pyrogenal, phonophoresis or electrophoresis with heparin. For estimating the therapy efficiency x-ray criteria of the size of residual pleural lesions after exudate resolution were developed. It was shown that inclusion of the pathogenetic treatment into combined therapy of the patients with tuberculous pleurisy markedly increased its efficiency and led to more favourable clinicoroentgenological outcomes. The results were especially favourable with tuberculin and successive application of the pathogenetic treatment corresponding to the process phase.
Tsymbalar'
G G
GG
Tudos
T P
TP
Zhurzha
L E
LE
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008070:Lipopolysaccharides / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D014373:Tuberculin / Q000008:administration & dosage*; D014396:Tuberculosis, Pleural / Q000188:drug therapy*; D014465:Ultrasonics
D008070:Lipopolysaccharides; D014373:Tuberculin; C009136:pyrogenal; D006493:Heparin; D011239:Prednisolone
Patogeneticheskie sredstva v kompleksnom lechenii bol'nykh tuberkuleznym plevritom.